ArticleMedicine2025
Infantile spasm, an unreported epilepsy form of CHD3 gene: A case report.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genotypic and Phenotypic Profile of 50 Cases With Chromatin Remodeling Complexes-Related Neurological Disorders.CNS neuroscience & therapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleCHD3 protein encoded by the CHD3 gene belongs to the second subfamily of the CHD family. The protein highly demonstrates in brain and is mostly in the developmental cortex. Its function is to promote the formation of late neural migration and cortex. Previously, CHD3 gene variants causing epilepsy are rare and only 1 case has been reported. The variation is a missense variant located at the C-terminal end of the deconvolution enzyme. However, there are no CHD3 gene mutations that have been reported to cause infantile spasms (IS) as yet. In the present study, we perform whole-exome sequencing (WES) in a patient of IS with neurodevelopmental disorders. This study suggests that CHD3 is potentially a candidate causative gene of IS. PATIENT CONCERNS: Children was admitted to our hospital for a detailed evaluation of frequent seizures. Children have abnormal electroencephalogram and brain magnetic resonance imaging results, accompanied by developmental delay. DIAGNOSES: A genetic study using trio-WES confirmed the diagnosis of CHD3-related IS.
interventionsPatient accepted the treatment of antiepileptic drugs. One patient had seizure remission with a combination of adrenocorticotropin and topiramate. OUTCOMES: Whole-exome sequencing technology was used to determine the etiology of the children with IS. The patient had gained seizure-free, and the follow-up electroencephalography discharges were reduced. LESSONS: This study confirmed that genetic testing provides a basis for the diagnosis of children with abnormal electroencephalogram and brain magnetic resonance imaging findings and developmental delay, and provides data supporting a future phenotype genotype correlation study. The CHD3 gene may be a new gene for IS, and the possibility of carrying a CHD3 gene variation should also be considered in children who present only with neurodevelopmental disorder without seizures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.